Hui Ding
Impact in
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
- Biomedical Engineering top 5%
- Nanoplatforms for cancer theranostics
- Graphene and Nanomaterials Applications
Papers in
-
- RNA Interference and Gene Delivery 14
- Advanced biosensing and bioanalysis techniques 7
- Biomaterials 14
- Nanoparticle-Based Drug Delivery 13
- Co-authors
- Julia Y. Ljubimova (30 shared papers)Keith L. Black (26 shared papers)Eggehard Holler (26 shared papers)Rameshwar Patil (25 shared papers)José Portilla‐Arias (17 shared papers)Bindu Konda (10 shared papers)Satoshi Inoue (8 shared papers)Alexander V. Ljubimov (11 shared papers)
- Journals
- Cancer Research (4 papers)Journal of Controlled Release (3 papers)Biomaterials (3 papers)Marine Drugs (2 papers)Journal of drug targeting (2 papers)
- Partner nations
- United StatesChinaGermany
In The Last Decade
Hui Ding
54 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 117
- Biomaterials 656
- Biomedical Engineering 479
- Genetics 110
- Molecular Biology 690
- Pharmaceutical Science 58
Countries citing papers authored by Hui Ding
This map shows the geographic impact of Hui Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui Ding more than expected).
Fields of papers citing papers by Hui Ding
This network shows the impact of papers produced by Hui Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui Ding. The network helps show where Hui Ding may publish in the future.
Co-authors
The 25 scholars most cited alongside Hui Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 136 | |
| 2 | 2010 | 130 | |
| 3 | 2010 | 74 | |
| 4 | 2010 | 74 | |
| 5 | 2015 | 73 | |
| 6 | 2019 | 70 | |
| 7 | 2012 | 67 | |
| 8 | 2016 | 62 | |
| 9 | 2007 | 59 | |
| 10 | 2011 | 52 | |
| 11 | 2011 | 48 | |
| 12 | 2012 | 45 | |
| 13 | 2010 | 45 | |
| 14 | 2013 | 44 | |
| 15 | 2016 | 42 | |
| 16 | 2013 | 37 | |
| 17 | 2019 | 37 | |
| 18 | 2015 | 34 | |
| 19 | 2016 | 31 | |
| 20 | 2023 | 28 |
About Hui Ding
Hui Ding is a scholar working on Molecular Biology, Biomaterials, Radiology, Nuclear Medicine and Imaging, Oncology and Biomedical Engineering, having authored 55 papers that have together received 1.6k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (14 papers), Nanoparticle-Based Drug Delivery (13 papers), Advanced biosensing and bioanalysis techniques (7 papers), Nanoplatforms for cancer theranostics (6 papers), Monoclonal and Polyclonal Antibodies Research (6 papers), Electrocatalysts for Energy Conversion (5 papers), Alzheimer's disease research and treatments (4 papers) and Advanced battery technologies research (4 papers). The work is most often cited by research in Biomaterials (656 citations), Biomedical Engineering (479 citations), Genetics (110 citations), Molecular Biology (690 citations) and Pharmaceutical Science (58 citations). Hui Ding has collaborated with scholars based in United States, China and Germany. Frequent co-authors include Julia Y. Ljubimova, Keith L. Black, Eggehard Holler, Rameshwar Patil, José Portilla‐Arias, Bindu Konda, Satoshi Inoue, Alexander V. Ljubimov, Jinwei Hu and Kolja Wawrowsky. Their work appears in journals such as Cancer Research, Journal of Controlled Release, Biomaterials, Marine Drugs and Journal of drug targeting.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.